Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

Anusha Gupta; Shiv Verma; Sanjay Gupta

doi:10.3390/cancers16203445

Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

Cancers (Basel). 2024 Oct 11;16(20):3445. doi: 10.3390/cancers16203445.

Authors

Anusha Gupta^{1

2}, Shiv Verma^{1

3}, Sanjay Gupta^{1

3

4

5

6

7}

Affiliations

¹ Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
² Faculty of Science Program, University of Western Ontario, London, ON N6A 5A5, Canada.
³ The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
⁴ Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44016, USA.
⁵ Department of Pathology, Case Western Reserve University, Cleveland, OH 44016, USA.
⁶ Department of Nutrition, Case Western Reserve University, Cleveland, OH 44016, USA.
⁷ Division of General Medical Sciences, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA.

Abstract

Bladder cancer, the sixth most common cancer and the tenth leading cause of cancer-related death worldwide, remains a significant global health concern [...].

Publication types

Editorial